| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.992 | 0 | 0.992 | Glycine receptor agonist | 0.991 0 DBMET03414 0.986 0 DBMET03415 | ||
| 0.945 | 0.001 | 0.945 | Bile acid receptor antagonist | 0.906 0.001 DBMET03414 0.788 0.001 DBMET03415 | ||
| 0.895 | 0.001 | 0.899 | Antibacterial | 0.899 0.001 DBMET03414 0.897 0.001 DBMET03415 | DBMET03414 | |
| 0.805 | 0.001 | 0.834 | ATPase inhibitor | 0.815 0.001 DBMET03414 0.834 0 DBMET03415 | DBMET03415 | |
| 0.807 | 0.012 | 0.836 | Transcription factor NF kappa B inhibitor | 0.836 0.011 DBMET03414 0.799 0.013 DBMET03415 | DBMET03414 | |
| 0.753 | 0 | 0.793 | Na+ K+ transporting ATPase inhibitor | 0.793 0 DBMET03414 0.774 0 DBMET03415 | DBMET03414 | |
| 0.707 | 0.005 | 0.722 | Immunosuppressant | 0.719 0.005 DBMET03414 0.722 0.005 DBMET03415 | DBMET03415 | |
| 0.721 | 0.027 | 0.741 | Apoptosis agonist | 0.728 0.026 DBMET03414 0.741 0.024 DBMET03415 | DBMET03415 | |
| 0.613 | 0.002 | 0.613 | Protein kinase stimulant | 0.59 0.003 DBMET03414 0.513 0.004 DBMET03415 | ||
| 0.609 | 0.003 | 0.618 | Antineoplastic antibiotic | 0.617 0.003 DBMET03414 0.618 0.003 DBMET03415 | DBMET03415 | |
| 0.596 | 0.005 | 0.596 | P-glycoprotein inhibitor | 0.595 0.005 DBMET03414 0.563 0.005 DBMET03415 | ||
| 0.521 | 0.029 | 0.521 | Cholesterol antagonist | 0.465 0.038 DBMET03414 0.39 0.052 DBMET03415 | ||
| 0.477 | 0.014 | 0.485 | Antimitotic | 0.468 0.015 DBMET03414 0.485 0.013 DBMET03415 | DBMET03415 | |
| 0.454 | 0.017 | 0.469 | DNA synthesis inhibitor | 0.454 0.017 DBMET03414 0.469 0.016 DBMET03415 | DBMET03415 | |
| 0.439 | 0.016 | 0.439 | Angiogenesis stimulant | 0.43 0.017 DBMET03414 0.412 0.02 DBMET03415 | ||
| 0.388 | 0.002 | 0.396 | Protein 50S ribosomal subunit inhibitor | 0.39 0.002 DBMET03414 0.396 0.002 DBMET03415 | DBMET03415 | |
| 0.382 | 0.013 | 0.432 | Melanin inhibitor | 0.405 0.011 DBMET03414 0.432 0.01 DBMET03415 | DBMET03415 | |
| 0.355 | 0.031 | 0.37 | Nitric oxide antagonist | 0.37 0.029 DBMET03414 0.366 0.029 DBMET03415 | DBMET03414 | |
| 0.301 | 0.002 | 0.301 | Microtubule formation inhibitor | 0.296 0.002 DBMET03414 0.299 0.002 DBMET03415 | ||
| 0.355 | 0.057 | 0.395 | Caspase 3 stimulant | 0.37 0.053 DBMET03414 0.395 0.046 DBMET03415 | DBMET03415 | |
| 0.3 | 0.015 | 0.304 | Interleukin 6 antagonist | 0.304 0.014 DBMET03414 0.269 0.019 DBMET03415 | DBMET03414 | |
| 0.334 | 0.064 | 0.37 | Apoptosis antagonist | 0.335 0.063 DBMET03414 0.37 0.048 DBMET03415 | DBMET03415 | |
| 0.285 | 0.03 | 0.302 | Peptidyltransferase inhibitor | 0.297 0.025 DBMET03414 0.302 0.024 DBMET03415 | DBMET03415 | |
| 0.211 | 0.008 | 0.211 | Multidrug resistance-associated protein 1 inhibitor | 0.21 0.008 DBMET03414 0.205 0.009 DBMET03415 | ||
| 0.199 | 0.001 | 0.209 | Antibiotic Macrolide-like | 0.203 0.001 DBMET03414 0.209 0.001 DBMET03415 | DBMET03415 | |
| 0.198 | 0.003 | 0.221 | ATPase (Vacuolar H+) inhibitor | 0.199 0.003 DBMET03414 0.221 0.002 DBMET03415 | DBMET03415 | |
| 0.263 | 0.077 | 0.281 | Antioxidant | 0.273 0.073 DBMET03414 0.281 0.069 DBMET03415 | DBMET03415 | |
| 0.19 | 0.045 | 0.279 | Interferon gamma antagonist | 0.206 0.039 DBMET03414 0.279 0.023 DBMET03415 | DBMET03415 | |
| 0.151 | 0.032 | 0.151 | Alpha 2c adrenoreceptor antagonist | 0.127 0.045 DBMET03414 0.098 0.068 DBMET03415 | ||
| 0.188 | 0.073 | 0.2 | Hepatoprotectant | 0.194 0.069 DBMET03414 0.2 0.065 DBMET03415 | DBMET03415 | |
| 0.125 | 0.013 | 0.154 | T cell inhibitor | 0.136 0.011 DBMET03414 0.154 0.009 DBMET03415 | DBMET03415 | |
| 0.154 | 0.048 | 0.183 | Topoisomerase II inhibitor | 0.163 0.044 DBMET03414 0.183 0.037 DBMET03415 | DBMET03415 | |
| 0.238 | 0.133 | 0.238 | Interleukin 2 agonist | 0.233 0.139 DBMET03414 0.231 0.141 DBMET03415 | ||
| 0.309 | 0.207 | 0.37 | Antiinflammatory | 0.331 0.188 DBMET03414 0.37 0.159 DBMET03415 | DBMET03415 | |
| 0.119 | 0.045 | 0.119 | Toll-Like receptor 4 antagonist | 0.115 0.049 DBMET03414 0.111 0.053 DBMET03415 | ||
| 0.073 | 0.005 | 0.074 | Microtubule stabilization | 0.073 0.005 DBMET03414 0.074 0.005 DBMET03415 | DBMET03415 | |
| 0.193 | 0.125 | 0.215 | Immunostimulant | 0.215 0.112 DBMET03414 0.207 0.116 DBMET03415 | DBMET03414 | |
| 0.11 | 0.043 | 0.117 | mTOR complex 1 inhibitor | 0.115 0.035 DBMET03414 0.117 0.032 DBMET03415 | DBMET03415 | |
| 0.088 | 0.033 | 0.094 | Selectin antagonist | 0.093 0.03 DBMET03414 0.094 0.03 DBMET03415 | DBMET03415 | |
| 0.074 | 0.026 | 0.074 | Protein kinase C eta inhibitor | 0.074 0.026 DBMET03414 0.062 0.033 DBMET03415 | ||
| 0.092 | 0.047 | 0.098 | Transcription factor NF kappa B stimulant | 0.096 0.043 DBMET03414 0.098 0.041 DBMET03415 | DBMET03415 | |
| 0.128 | 0.083 | 0.134 | Neurotrophic factor | 0.134 0.075 DBMET03414 0.121 0.093 DBMET03415 | DBMET03414 | |
| 0.115 | 0.07 | 0.132 | Cholesterol synthesis inhibitor | 0.127 0.059 DBMET03414 0.132 0.055 DBMET03415 | DBMET03415 | |
| 0.115 | 0.073 | 0.136 | Alkylator | 0.125 0.063 DBMET03414 0.136 0.055 DBMET03415 | DBMET03415 | |
| 0.107 | 0.071 | 0.112 | Interleukin 2 antagonist | 0.112 0.059 DBMET03414 | DBMET03414 | |
| 0.103 | 0.068 | 0.125 | Topoisomerase I inhibitor | 0.112 0.06 DBMET03414 0.125 0.053 DBMET03415 | DBMET03415 | |
| 0.048 | 0.014 | 0.051 | Antibiotic Aminoglycoside-like | 0.05 0.013 DBMET03414 0.051 0.013 DBMET03415 | DBMET03415 | |
| 0.044 | 0.011 | 0.046 | Tubulin agonist | 0.044 0.012 DBMET03414 0.046 0.01 DBMET03415 | DBMET03415 | |
| 0.142 | 0.115 | 0.152 | Platelet adhesion inhibitor | 0.143 0.114 DBMET03414 0.152 0.103 DBMET03415 | DBMET03415 | |
| 0.059 | 0.038 | 0.059 | Lipocortins synthesis agonist | 0.058 0.04 DBMET03414 0.058 0.04 DBMET03415 | ||
| 0.026 | 0.012 | 0.028 | Motilin receptor agonist | 0.026 0.012 DBMET03414 0.028 0.01 DBMET03415 | DBMET03415 | |
| 0.07 | 0.061 | 0.072 | Topoisomerase II alpha inhibitor | 0.072 0.059 DBMET03415 | DBMET03415 | |
| 0.077 | 0.069 | 0.078 | Antineoplastic alkaloid | 0.078 0.067 DBMET03415 | DBMET03415 | |
| 0.012 | 0.007 | 0.014 | Calcineurin inhibitor | 0.013 0.006 DBMET03414 0.014 0.005 DBMET03415 | DBMET03415 | |
| 0.023 | 0.018 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.023 0.017 DBMET03414 0.025 0.016 DBMET03415 | DBMET03415 | |
| 0.115 | 0.125 | 0.148 | NOS3 expression enhancer | 0.135 0.09 DBMET03414 0.148 0.075 DBMET03415 | DBMET03415 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |